CollPlant Biotechnologies Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $58.38 million, with shareholders equity totaling $4.89 million.
The company employs approximately 52 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, CollPlant Biotechnologies Ltd. reported $390.00 Thousand in revenue, generating net income of $-13.14 million.
Key financial metrics include a P/E ratio of -4.44, a price-to-book (P/B) ratio of 11.94, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CLGN.